10-K: Hercules Capital Reports Strong 2025 Performance, Strategic Growth

Hercules Capital, Inc. reported a robust financial performance for the fiscal year ended December 31, 2025, driven by increased investment income and strategic portfolio expansion.

Summary

• Hercules Capital's primary business objectives are to increase net income, net investment income, and net asset value (NAV) through investments in Structured Debt and senior secured loans to high-growth, innovative venture capital-backed and institutional-backed companies in technology and life sciences industries.
• Since inception through December 31, 2025, the company has originated over $25.0 billion in commitments across more than 700 companies.
• As of December 31, 2025, the company, including its Adviser Subsidiary, actively manages over $5.7 billion of assets.
• Net investment income for 2025 increased to $341.7 million, up from $325.8 million in 2024.
• The net increase in net assets resulting from operations for 2025 was $339.7 million, compared to $263.0 million in 2024.
• The total investment portfolio's fair value grew to $4,466.6 million as of December 31, 2025, from $3,660.0 million in 2024.
• As of December 31, 2025, approximately 97.9% of debt investments were at floating rates (with a floor) and 2.1% were at fixed rates.
• The weighted average investment grading improved slightly to 2.20 (on a cost basis) as of December 31, 2025, from 2.26 in 2024.
• Unfunded contractual commitments totaled $385.6 million as of December 31, 2025, with an additional $814.6 million in non-binding term sheets outstanding.
• The total return for investors was 3.2% in 2025, a significant decrease from 32.8% in 2024.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a generally positive report, reflecting strong growth in net investment income and portfolio size, coupled with an improved portfolio quality rating. However, the significant drop in total return for investors and increased realized losses temper the overall sentiment, suggesting underlying challenges despite operational expansion.

Positives

• Net investment income increased to $341.7 million in 2025 from $325.8 million in 2024, demonstrating strong operational performance.
• Net increase in net assets resulting from operations rose to $339.7 million in 2025 from $263.0 million in 2024.
• The total investment portfolio's fair value grew significantly to $4,466.6 million in 2025 from $3,660.0 million in 2024, indicating successful portfolio expansion.
• Gross debt fundings by Hercules Capital and the Adviser Funds increased to $2,259.9 million in 2025 from $1,795.2 million in 2024.
• Net total investment commitments increased to $2,895.9 million in 2025 from $2,130.6 million in 2024.
• The weighted average investment grading improved slightly to 2.20 in 2025 from 2.26 in 2024, suggesting an improvement in overall portfolio quality.
• Approximately 97.9% of debt investments are at floating rates with a floor, providing a degree of insulation against potential declines in interest rates.
• The company maintained ample liquidity of $525.5 million as of December 31, 2025, including cash and available borrowing capacity.
• The asset coverage ratio of 212.1% (excluding SBA debentures) as of December 31, 2025, is well above the 150% regulatory minimum, indicating strong financial health.
• The fair value of the warrant portfolio increased by approximately $10.6 million to $41.1 million in 2025.
• The company has achieved significant multiples on monetized warrants since inception, ranging from approximately 1.02x to 42.71x.

Negatives

• The total return for investors significantly decreased to 3.2% in 2025 from 32.8% in 2024.
• Net realized loss increased to $40.8 million in 2025 from $31.7 million in 2024.
• A foreign exchange loss of $2.1 million was recognized in 2025.
• PIK interest receivable increased to $109.1 million in 2025 from $67.7 million in 2024, representing 3% of total debt investments, which indicates a higher proportion of non-cash interest income.
• Fee income decreased to $24.6 million in 2025 from $26.4 million in 2024, primarily due to lower prepayment penalties.
• Operating expenses increased to $190.8 million in 2025 from $167.8 million in 2024, driven by higher interest and fees on debt and increased employee compensation.
• Unrealized appreciation on portfolio investments was partially offset by depreciation of equity investments during 2025.
• Approximately 50% of warrants may not realize any exit or generate returns, potentially leading to realized losses upon expiration or non-exercise.

Risks

• Operating in a highly competitive market for investment opportunities may force the company to accept less attractive investment terms.
• Dependence on senior management, particularly CEO Scott Bluestein, and other key personnel for investment identification, structuring, closing, and monitoring.
• Challenges in attracting and retaining qualified personnel in a competitive market, potentially limited by 1940 Act restrictions on compensation structures.
• Reliance on strong referral relationships for investment opportunities, which are not guaranteed to generate future deals.
• The Board of Directors can modify or waive operating policies and strategies without prior notice or stockholder approval, potentially with adverse effects.
• Investments in portfolio companies involve significant risks, including limited financial resources, need for additional financing, shorter operating histories, dependence on small management teams, unpredictable operating results, and limited public information.
• The illiquidity of investments may make it difficult to sell them at a favorable price or at all, potentially leading to losses.
• Concentration in certain technology-related industries (Application Software, Drug Discovery & Development, Healthcare Services, Other, System Software, Consumer & Business Services) subjects the company to significant loss if these industries experience a downturn.
• As a non-diversified investment company, the company is not limited by the 1940 Act in the proportion of assets invested in a single issuer, increasing the impact of underperforming investments.
• Investments with PIK interest or exit fees carry higher risks due to income recognition prior to cash receipt and potentially unreliable valuations.
• The company may not have sufficient funds or ability to make additional investments in portfolio companies, potentially harming those companies or diluting existing interests.
• Debt investments could be subordinated to claims of other creditors or subject to lender liability claims, especially if significant managerial assistance is provided.
• The company generally does not control its portfolio companies, which may lead to business decisions adverse to its interests.
• Defaults by portfolio companies will harm operating results, and collateral may not be sufficient to cover indebtedness.
• Substantially all portfolio investments are recorded at fair value (Level 3), leading to inherent uncertainty and potential significant differences from ultimately realized values.
• Substantial borrowings (leverage) magnify the potential for loss and increase investment risk.
• Certain assets are subject to security interests under senior securities, risking foreclosure upon default.
• Inability to renew, extend, or replace credit facilities could adversely impact liquidity and ability to fund new investments or maintain distributions.
• Conflicts of interest may arise from executive officers and employees managing Adviser Funds that operate in the same or related lines of business.
• Revenues from managing third-party funds may be terminated, negatively impacting operating results.
• Failure to comply with applicable laws or regulations (e.g., 1940 Act, RIC status, SBIC regulations) could adversely affect business or require strategy alteration.
• Operating under BDC and RIC constraints may hinder the achievement of investment objectives.
• Regulations governing BDC operations affect the ability to raise additional capital, potentially leading to dilution if shares are sold below NAV.
• The market price of securities may be volatile and fluctuate significantly due to various factors.
• The company may not be able to pay distributions to stockholders, distributions may not grow, and a portion may be a return of capital.
• Stockholders may experience dilution upon conversion of 2028 Convertible Notes if common stock is issued when NAV per share exceeds the conversion price.
• Unsecured notes are effectively subordinated to secured indebtedness and structurally subordinated to subsidiaries' liabilities.
• Lack of an active trading market for certain notes could limit holders' ability to resell them.
• A downgrade, suspension, or withdrawal of credit ratings could cause the liquidity or market value of debt securities to decline significantly.
• The indentures for certain notes (2033, September 2026, January 2027, 2028 Convertible, June 2030) offer limited protections to holders.
• The company may not be able to prepay notes upon a change in control or fundamental change.
• The SBA, as a creditor, has superior claims on the assets of SBIC subsidiaries over the company's securities holders.
• SBIC subsidiaries may be unable to make distributions necessary to maintain RIC status, potentially leading to entity-level tax.
• Difficulty paying distributions required for RIC status if income is recognized before or without receiving cash (e.g., OID, PIK income).
• The company may choose to pay distributions in its own stock, requiring stockholders to pay tax in excess of cash received.
• Legislative or regulatory tax changes could adversely affect the company's stockholders.
• FATCA withholding may apply to payments made to certain foreign entities.
• Capital markets may experience periods of disruption and instability, negatively impacting the business and portfolio companies.
• Risks related to corporate social responsibility, including damage to brand and reputation.
• High dependence on information systems; systems failures or cyber-attacks could significantly disrupt business.
• The company may be the target of litigation, including securities litigation and lender liability claims.
• Technological innovations and industry disruptions, including those related to artificial intelligence and machine learning, may negatively impact the company.

Future Outlook

The company intends to continue generating cash flows from operations, including income from portfolio investments, with primary uses of funds being new investments and cash distributions to common stockholders. It plans to raise additional equity or debt capital through various offerings, securitizations, or SBA borrowings. The company monitors macroeconomic market developments and their impact, focusing its investment portfolio on industries and sectors expected to be resilient to U.S. and global economic cycles, and believes it is well-positioned to manage the current environment.

Management Comments

• Our primary business objectives are to increase our net income, net investment income, and net asset value (NAV) through our investments in primarily Structured Debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields.
• We aim to achieve our business objectives by maximizing our portfolio total return through generation of current income from our debt investments and capital appreciation from our warrant and equity investments.
• We believe that the perpetual nature of our corporate structure enables us to be a long-term partner for our portfolio companies in contrast to traditional investment funds, which typically have a limited life.
• We believe that our assets provide adequate cover to satisfy all of our unfunded commitments and we intend to use cash flow from operations and early principal repayments and proceeds from borrowings and notes to fund these commitments.
• Currently, we believe we have ample liquidity to support our near-term capital requirements.

Industry Context

StockSavvy.ai notes that Hercules Capital operates in the specialty finance sector, focusing on high-growth technology and life sciences companies. This niche allows them to capitalize on the underserved market for structured debt financing to venture capital-backed firms, which often struggle with traditional lenders due to unique cash flow characteristics and intellectual property-heavy balance sheets. The continued activity in the venture capital market, despite broader economic uncertainties, suggests a sustained demand for their complementary debt products that minimize equity dilution for portfolio companies and their financial sponsors. The company's strategy of investing across various development stages and sub-sectors within these industries positions it to mitigate some of the inherent volatility of these high-growth markets.

Comparison to Industry Standards

• The filing does not explicitly compare its performance to specific comparable companies, projects, or global benchmarks.
• The company states that many of its competitors are substantially larger and have considerably greater financial, technical, marketing, and other resources.
• The company believes few competitors possess its level of expertise in properly structuring and pricing debt investments to venture capital-backed and institutional capital-backed companies in technology-related industries.

Corporate Governance

Legal Proceedings

• The company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise.
• Third parties may try to seek to impose liability on the company in connection with the activities of its portfolio companies.
• The outcome of any current legal proceedings cannot at this time be predicted with certainty, but the company does not expect any current matters to materially affect its financial condition or results of operations.

Related Party Transactions

• The Adviser Subsidiary, a wholly-owned registered investment adviser business, provides investment advisory and related services to privately offered Adviser Funds owned by unrelated third-party investors.
• Hercules Partner Holdings, LLC, also wholly-owned by the company, holds general partner interests in the Adviser Funds and may receive incentive fees.
• Dividend income from the Adviser Subsidiary was $8.2 million in 2025, up from $6.8 million in 2024.
• Interest income from the Adviser Subsidiary was $0.6 million in 2024, with none reported in 2025.
• Expenses allocated to the Adviser Subsidiary under a shared services agreement totaled $15.2 million in 2025, up from $10.8 million in 2024.
• A receivable from the Adviser Subsidiary was $1.7 million as of December 31, 2025, compared to less than $0.1 million in 2024.
• The company may make investments alongside the Adviser Funds or assign portions of investments to them.
• On July 31, 2025, the company sold $20.0 million of assets to the Adviser Funds at fair value.
• Investment commitments assigned to or directly committed by the Adviser Funds totaled $1,028.4 million in 2025, up from $562.1 million in 2024.
• Investment fundings assigned to or directly funded by the Adviser Funds amounted to $579.1 million in 2025, up from $383.2 million in 2024.
• Unfunded commitments related to loans assigned to or directly committed by the Adviser Funds, and thus excluded from the company's total unfunded commitments, were $96.2 million in 2025, down from $139.7 million in 2024.

Stakeholder Impact

• Shareholders: Potential for increased net income and NAV, but also dilution risk from equity offerings below NAV, volatility in market price, and distributions potentially being a return of capital. Total return for investors was significantly lower in 2025 compared to 2024.
• Employees: The company is committed to attracting, developing, and retaining talent with competitive compensation, benefits, and professional development opportunities. The corporate culture emphasizes open communication, anti-harassment, and diversity.
• Portfolio Companies: Benefit from customized financing solutions, growth capital, and a long-term partnership. Companies may be subject to monitoring and potential workout strategies if underperforming.
• Lenders/Creditors: Face senior claims on assets, financial and operational covenants, and the risk of foreclosure upon default. Unsecured notes are effectively subordinated to secured debt.
• Regulatory Bodies: The company is subject to extensive regulations from the SEC, NYSE, SBA, and other authorities, with compliance being a significant operational aspect.

Next Steps

• Pay a fourth quarter cash distribution of $0.40 per share on March 4, 2026.
• Pay a first quarterly supplemental cash distribution of $0.07 per share (part of a $0.28 supplemental distribution) on March 4, 2026.
• Continue to evaluate the overall liquidity position and take proactive steps to maintain appropriate liquidity based on macroeconomic events.
• Hercules Capital IV, L.P. (HC IV) will only satisfy contractually agreed-upon follow-on fundings to existing portfolio companies, as its investment period concluded on October 27, 2025.
• HC IV may seek to pay off a portion or all of its outstanding debentures early as per available liquidity.
• Monitor compliance with all future NYSE listing standards.
• Continue to monitor macroeconomic market developments and their related impact to the business.
• May seek stockholder authorization to issue common stock at a price below NAV per share at future annual or special meetings.
• May issue additional equity or debt capital through registered offerings, ATM offerings, private offerings, securitizing investments, or borrowing from the SBA through SBIC subsidiaries.

Key Dates

Recommendation

The company demonstrates strong operational growth in net investment income and portfolio size, coupled with an improved portfolio quality rating and robust liquidity. However, the substantial decrease in total return for investors and increased net realized losses in 2025 suggest that while the underlying business is expanding, it faces challenges in translating this into direct shareholder value appreciation in the short term. The ongoing macroeconomic uncertainties and the inherent risks of investing in high-growth, illiquid private companies warrant a cautious approach. The strategic expansion into Adviser Funds and continued capital raises indicate a growth-oriented strategy, but the immediate impact on shareholder returns is mixed.

Keywords

Venture debt, Specialty finance, Senior secured loans, Technology, Life sciences, BDC, RIC, Private equity, Structured debt, Warrants, Equity investments, Asset management, Credit, Portfolio management, SEC filings, Corporate governance, Risk management, Application software, Drug discovery & development, Healthcare services, System software, Consumer & business services